SEC Form 4 · accession 0001193125-26-261835
ClearPoint Neuro, Inc. · CLPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy T. Richards
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001285550
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2026 | M | 500 | $10.00 | A | 87,698 | D | |
| Common Stock | Jun 4, 2026 | F | 376 | $13.30 | D | 87,322 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $10.00 | Jun 4, 2026 | M | 500 | D | Jun 8, 2017 | Jun 8, 2026 | Common Stock | 500 | 0 | D |
Explanation of responses
- F1This option was previously reported as covering 20,000 shares at an exercise price of $0.25 per share, but was adjusted to reflect the stock split that occurred on July 27, 2016.